Bio-Techne TECH
NASDAQ TECH
$72.43 -0.02 (-0.03%)
As of: Sep 4, 2026 · 3:59 PM EDT

Bio-Techne (TECH) Price to Earnings (2009 - 2026)

Analysis

Bio-Techne (TECH) Price to Earnings (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Bio-Techne 11.29 Bn 11.03 Bn 211.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 201.90
Mar 31, 2026 160.24
Dec 31, 2025 241.19
Sep 30, 2025 226.90
Jun 30, 2025 -115.84
Mar 31, 2025 406.89
Dec 31, 2024 326.02
Sep 30, 2024 377.95
Jun 30, 2024 26,548.47
Mar 31, 2024 226.06
Dec 31, 2023 441.47
Sep 30, 2023 211.39
Jun 30, 2023 281.67
Mar 31, 2023 166.24
Dec 31, 2022 260.37
Sep 30, 2022 124.17
Jun 30, 2022 219.24
Mar 31, 2022 282.70
Dec 31, 2021 282.29
Sep 30, 2021 275.88